• FirefoxInstall the new Firefox »
  •  Dow Up 0.86% Nasdaq Up 0.90%

    Novo Nordisk A/S (NVO)

    -NYSE
    47.51 Down 0.24(0.50%) 4:03PM EST
    |After Hours : 47.51 0.00 (0.00%) 4:03PM EST - NYSE Real Time Price
    Add to Portfolio
    Prev Close:47.75
    Open:47.64
    Bid:47.52 x 1400
    Ask:47.53 x 2800
    1y Target Est:58.52
    Beta:0.75
    Next Earnings Date:N/A
    Day's Range:47.42 - 47.77
    52wk Range:41.72 - 49.11
    Volume:890,845
    Avg Vol (3m):1,362,160
    Market Cap:123.51B
    P/E (ttm):31.42
    EPS (ttm):1.51
    Div & Yield:0.76 (1.60%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVODown 0.50%123.51B
    LLYUp 1.35%75.43B
    PFEUp 1.31%213.10B
    SNYDown 1.17%127.08B

    Key Statistics

    Forward P/E (1 yr):25.28
    P/S (ttm):9.31
    Ex-Dividend Date:19-Mar-15

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Jun-14) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback